Filing Details
- Accession Number:
- 0001731122-21-001126
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-01 21:45:55
- Reporting Period:
- 2021-06-29
- Accepted Time:
- 2021-07-01 21:45:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314052 | Anavex Life Sciences Corp. | AVXL | Services-Commercial Physical & Biological Research (8731) | 208365999 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1655366 | Sandra Boenisch | 51 West 52Nd Street, 7Th Floor New York NY 10019 | Pfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-29 | 25,000 | $5.68 | 47,963 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 106,696 | $3.28 | 154,659 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 35,000 | $5.92 | 189,659 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-29 | 166,696 | $26.53 | 22,963 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-29 | 25,000 | $0.00 | 25,000 | $5.68 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-29 | 106,696 | $0.00 | 106,696 | $3.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-29 | 35,000 | $0.00 | 35,000 | $5.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-10-02 | No | 4 | M | Direct | |
| 0 | 2016-09-22 | 2026-09-22 | No | 4 | M | Direct |
| 0 | 2027-05-12 | No | 4 | M | Direct |
Footnotes
- The options subject to this grant vested quarterly over a three-year period commencing on December 31, 2015.
- The options subject to this grant vested quarterly over a three-year period commencing on June 30, 2017.
Billionaire Hedge Funds
